{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T14:00:31Z","timestamp":1742997631480,"version":"3.40.3"},"publisher-location":"Cham","reference-count":225,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031023774"},{"type":"electronic","value":"9783031023781"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/5584_2021_675","type":"book-chapter","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T15:04:40Z","timestamp":1642172680000},"page":"1-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular Mechanisms of SARS-CoV-2\/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions"],"prefix":"10.1007","author":[{"given":"Stanislav A.","family":"Groppa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dumitru","family":"Ciolac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Gasna\u0219","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Leahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Efremova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Gasna\u0219","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"B\u0103l\u0103nu\u021b\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"M\u00eerzac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Movila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"675_CR1","volume-title":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses\u2013a statement of the Coronavirus Study Group","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya, A.E., et al., Severe acute respiratory syndrome-related coronavirus: the species and its viruses\u2013a statement of the Coronavirus Study Group. 2020"},{"key":"675_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijid.2020.02.052","volume":"93","author":"E Petersen","year":"2020","unstructured":"Petersen E et al (2020) Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak. Int J Infect Dis 93:205\u2013207","journal-title":"Int J Infect Dis"},{"issue":"10273","key":"675_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(21)00298-1","volume":"397","author":"T Burki","year":"2021","unstructured":"Burki T (2021) Understanding variants of SARS-CoV-2. Lancet 397(10273):462","journal-title":"Lancet"},{"issue":"3","key":"675_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41591-021-01265-1","volume":"27","author":"AN Happi","year":"2021","unstructured":"Happi AN, Ugwu CA, Happi CT (2021) Tracking the emergence of new SARS-CoV-2 variants in South Africa. Nat Med 27(3):372\u2013373","journal-title":"Nat Med"},{"issue":"3","key":"675_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jobm.202000537","volume":"61","author":"SB Kadam","year":"2021","unstructured":"Kadam SB et al (2021) SARS-CoV-2, the pandemic coronavirus: molecular and structural insights. J Basic Microbiol 61(3):180\u2013202","journal-title":"J Basic Microbiol"},{"key":"675_CR6","doi-asserted-by":"crossref","unstructured":"Jakhmola S et al (2020) SARS-CoV-2, an underestimated pathogen of the nervous system. SN comprehensive clinical medicine:1\u201310","DOI":"10.1007\/s42399-020-00522-7"},{"issue":"1","key":"675_CR7","first-page":"190","volume":"23","author":"S Groppa","year":"2020","unstructured":"Groppa S et al (2020) Patologia neurologic\u0103 \u00een contextul pandemiei SARS-CoV-2. Revista de \u015etiin\u0163e ale S\u0103n\u0103t\u0103\u0163ii din Moldova 23(1):190\u2013208","journal-title":"Revista de \u015etiin\u0163e ale S\u0103n\u0103t\u0103\u0163ii din Moldova"},{"issue":"3","key":"675_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4269\/ajtmh.20-0447","volume":"103","author":"MTT Silva","year":"2020","unstructured":"Silva MTT, Lima M, Araujo AQC (2020) SARS-CoV-2: should we be concerned about the nervous system? Am J Trop Med Hygiene 103(3):993\u2013998","journal-title":"Am J Trop Med Hygiene"},{"key":"675_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T et al (2020) A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55\u201358","journal-title":"Int J Infect Dis"},{"key":"675_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","volume":"87","author":"Y Wu","year":"2020","unstructured":"Wu Y et al (2020a) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18\u201322","journal-title":"Brain Behav Immun"},{"key":"675_CR11","doi-asserted-by":"publisher","first-page":"135528","DOI":"10.1016\/j.neulet.2020.135528","volume":"742","author":"SS Mukerji","year":"2021","unstructured":"Mukerji SS, Solomon IH (2021) What can we learn from brain autopsies in COVID-19? Neurosci Lett 742:135528\u2013135528","journal-title":"Neurosci Lett"},{"key":"675_CR12","unstructured":"Serrano GE et al (2021) Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. medRxiv"},{"issue":"7","key":"675_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM et al (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995\u2013998","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"675_CR14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"DE Ribeiro","year":"2021","unstructured":"Ribeiro DE et al (2021) Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 26(4):1044\u20131059","journal-title":"Mol Psychiatry"},{"key":"675_CR15","doi-asserted-by":"crossref","unstructured":"Septyaningtrias DE, Susilowati R (2021) Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences. Rev Neurosci","DOI":"10.1515\/revneuro-2020-0092"},{"key":"675_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbrc.2021.01.104","volume":"546","author":"C Duarte","year":"2021","unstructured":"Duarte C et al (2021) Age-dependent effects of the recombinant spike protein\/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro. Biochem Biophys Res Commun 546:97\u2013102","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"675_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMc2011400","volume":"383","author":"VG Puelles","year":"2020","unstructured":"Puelles VG et al (2020) Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 383(6):590\u2013592","journal-title":"N Engl J Med"},{"issue":"11","key":"675_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19(11):919\u2013929","journal-title":"Lancet Neurol"},{"issue":"10","key":"675_CR19","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.7150\/ijbs.45498","volume":"16","author":"N Yang","year":"2020","unstructured":"Yang N, Shen HM (2020) Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int J Biol Sci 16(10):1724\u20131731","journal-title":"Int J Biol Sci"},{"issue":"10","key":"675_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMc2019373","volume":"383","author":"IH Solomon","year":"2020","unstructured":"Solomon IH et al (2020) Neuropathological features of Covid-19. N Engl J Med 383(10):989\u2013992","journal-title":"N Engl J Med"},{"issue":"3","key":"675_CR21","doi-asserted-by":"publisher","first-page":"e20202135","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218(3):e20202135","journal-title":"J Exp Med"},{"issue":"14","key":"675_CR22","doi-asserted-by":"publisher","first-page":"e2016","DOI":"10.1212\/WNL.0000000000010116","volume":"95","author":"T Coolen","year":"2020","unstructured":"Coolen T et al (2020) Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology 95(14):e2016\u2013e2027","journal-title":"Neurology"},{"issue":"6","key":"675_CR23","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/bpa.12889","volume":"30","author":"J Kantonen","year":"2020","unstructured":"Kantonen J et al (2020) Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol 30(6):1012\u20131016","journal-title":"Brain Pathol"},{"issue":"7","key":"675_CR24","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","volume":"1","author":"B Schurink","year":"2020","unstructured":"Schurink B et al (2020) Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 1(7):e290\u2013e299","journal-title":"Lancet Microbe"},{"issue":"7","key":"675_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi A et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92(7):699\u2013702","journal-title":"J Med Virol"},{"key":"675_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-81-322-1777-0_6","volume":"807","author":"M Desforges","year":"2014","unstructured":"Desforges M et al (2014) Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 807:75\u201396","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"675_CR27","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","volume":"77","author":"AS Zubair","year":"2020","unstructured":"Zubair AS et al (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus Disease 2019: a review. JAMA Neurol 77(8):1018\u20131027","journal-title":"JAMA Neurol"},{"issue":"5","key":"675_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1189\/jlb.0503207","volume":"74","author":"WK Kim","year":"2003","unstructured":"Kim WK et al (2003) Monocyte\/macrophage traffic in HIV and SIV encephalitis. J Leukoc Biol 74(5):650\u2013656","journal-title":"J Leukoc Biol"},{"issue":"18","key":"675_CR29","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1021\/acschemneuro.0c00434","volume":"11","author":"FJ Barrantes","year":"2020","unstructured":"Barrantes FJ (2020) Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem Neurosci 11(18):2793\u20132803","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"675_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1997.8609","volume":"233","author":"TC Nash","year":"1997","unstructured":"Nash TC, Buchmeier MJ (1997) Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways. Virology 233(1):1\u20138","journal-title":"Virology"},{"key":"675_CR31","volume-title":"Glia in Health and Disease","author":"J de Mattos Coelho-Aguiar","year":"2019","unstructured":"de Mattos Coelho-Aguiar J et al (2019) The enteric glial network acts in the maintenance of intestinal homeostasis and in intestinal disorders. In: Glia in Health and Disease. IntechOpen"},{"issue":"6499","key":"675_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers MM et al (2020) SARS-CoV-2 productively infects human gut enterocytes. Science 369(6499):50\u201354","journal-title":"Science"},{"issue":"6","key":"675_CR33","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","volume":"158","author":"F Xiao","year":"2020","unstructured":"Xiao F et al (2020) Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158(6):1831\u20131833. e3","journal-title":"Gastroenterology"},{"issue":"7","key":"675_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jmv.25825","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020a) The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol 92(7):833\u2013840","journal-title":"J Med Virol"},{"key":"675_CR35","doi-asserted-by":"crossref","unstructured":"Tang YW et al (2020) Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol 58(6)","DOI":"10.1128\/JCM.00512-20"},{"issue":"5","key":"675_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S2468-1253(20)30083-2","volume":"5","author":"Y Wu","year":"2020","unstructured":"Wu Y et al (2020b) Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 5(5):434\u2013435","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"675_CR37","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","volume":"69","author":"X Jin","year":"2020","unstructured":"Jin X et al (2020) Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 69(6):1002\u20131009","journal-title":"Gut"},{"issue":"3","key":"675_CR38","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/jmv.26521","volume":"93","author":"J Dey","year":"2021","unstructured":"Dey J et al (2021) Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain. J Med Virol 93(3):1296\u20131303","journal-title":"J Med Virol"},{"issue":"1","key":"675_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42269-020-00478-7","volume":"45","author":"G Ibrahim Fouad","year":"2021","unstructured":"Ibrahim Fouad G (2021) The neuropathological impact of COVID-19: a review. Bull Natl Res Cent 45(1):19","journal-title":"Bull Natl Res Cent"},{"issue":"5","key":"675_CR40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11684-020-0786-5","volume":"14","author":"Z Li","year":"2020","unstructured":"Li Z et al (2020a) Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med 14(5):533\u2013541","journal-title":"Front Med"},{"key":"675_CR41","doi-asserted-by":"crossref","unstructured":"Iadecola C, Anrather J, Kamel H (2020a) Effects of COVID-19 on the nervous system. Cell","DOI":"10.1016\/j.cell.2020.08.028"},{"issue":"3","key":"675_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20050828","volume":"202","author":"J Gu","year":"2005","unstructured":"Gu J et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202(3):415\u2013424","journal-title":"J Exp Med"},{"issue":"7","key":"675_CR43","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.cell.2020.05.006","volume":"181","author":"P Bost","year":"2020","unstructured":"Bost P et al (2020) Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell 181(7):1475\u20131488. e12","journal-title":"Cell"},{"issue":"Pt 7","key":"675_CR44","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1099\/vir.0.81624-0","volume":"87","author":"M Spiegel","year":"2006","unstructured":"Spiegel M et al (2006) Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J Gen Virol 87(Pt 7):1953\u20131960","journal-title":"J Gen Virol"},{"key":"675_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","volume":"11","author":"PA Swanson 2nd","year":"2015","unstructured":"Swanson, P.A., 2nd And D.B. McGavern, Viral diseases of the central nervous system. Curr Opin Virol, 2015. 11: p. 44\u201354","journal-title":"Curr Opin Virol"},{"issue":"4","key":"675_CR46","first-page":"665","volume":"37","author":"CK Bullen","year":"2020","unstructured":"Bullen CK et al (2020) Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. ALTEX 37(4):665\u2013671","journal-title":"ALTEX"},{"key":"675_CR47","doi-asserted-by":"crossref","unstructured":"Fenrich M et al (2020) SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury. Front Cell Neurosci 14(229)","DOI":"10.3389\/fncel.2020.00229"},{"issue":"2","key":"675_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt J et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24(2):168\u2013175","journal-title":"Nat Neurosci"},{"issue":"6","key":"675_CR49","doi-asserted-by":"publisher","first-page":"678","DOI":"10.23736\/S0375-9393.20.14772-2","volume":"86","author":"G Bulfamante","year":"2020","unstructured":"Bulfamante G et al (2020) First ultrastructural autoptic findings of SARS -Cov-2 in olfactory pathways and brainstem. Minerva Anestesiol 86(6):678\u2013679","journal-title":"Minerva Anestesiol"},{"key":"675_CR50","doi-asserted-by":"crossref","unstructured":"Pennisi M et al (2020) SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms. Int J Mol Sci 21(15)","DOI":"10.3390\/ijms21155475"},{"issue":"15","key":"675_CR51","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J et al (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264\u20137275","journal-title":"J Virol"},{"issue":"1","key":"675_CR52","doi-asserted-by":"publisher","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","volume":"292","author":"MF Doobay","year":"2007","unstructured":"Doobay MF et al (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 292(1):R373\u2013R381","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"675_CR53","doi-asserted-by":"crossref","unstructured":"Kumari P et al (2021) Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses 13(1)","DOI":"10.3390\/v13010132"},{"key":"675_CR54","doi-asserted-by":"crossref","unstructured":"Brann DH et al (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 6(31)","DOI":"10.1126\/sciadv.abc5801"},{"key":"675_CR55","doi-asserted-by":"publisher","first-page":"118063","DOI":"10.1016\/j.lfs.2020.118063","volume":"257","author":"H Yavarpour-Bali","year":"2020","unstructured":"Yavarpour-Bali H, Ghasemi-Kasman M (2020) Update on neurological manifestations of COVID-19. Life Sci 257:118063","journal-title":"Life Sci"},{"key":"675_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2020.04.060","volume":"87","author":"G Esposito","year":"2020","unstructured":"Esposito G et al (2020) Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Brain Behav Immun 87:93\u201394","journal-title":"Brain Behav Immun"},{"issue":"6","key":"675_CR57","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"YC Li","year":"2020","unstructured":"Li YC, Bai WZ, Hashikawa T (2020b) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92(6):552\u2013555","journal-title":"J Med Virol"},{"key":"675_CR58","doi-asserted-by":"publisher","first-page":"102656","DOI":"10.1016\/j.autneu.2020.102656","volume":"225","author":"CG Parker","year":"2020","unstructured":"Parker CG et al (2020) Central sensory-motor crosstalk in the neural gut-brain axis. Auton Neurosci 225:102656","journal-title":"Auton Neurosci"},{"key":"675_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnana.2020.00037","volume":"14","author":"MF DosSantos","year":"2020","unstructured":"DosSantos MF et al (2020) Neuromechanisms of SARS-CoV-2: a review. Front Neuroanat 14:37","journal-title":"Front Neuroanat"},{"issue":"1","key":"675_CR60","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","volume":"9","author":"JJ Lochhead","year":"2019","unstructured":"Lochhead JJ et al (2019) Distribution of insulin in trigeminal nerve and brain after intranasal administration. Sci Rep 9(1):2621","journal-title":"Sci Rep"},{"issue":"10226","key":"675_CR61","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","volume":"395","author":"H Chen","year":"2020","unstructured":"Chen H et al (2020b) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395(10226):809\u2013815","journal-title":"Lancet"},{"issue":"1","key":"675_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40902-020-00254-7","volume":"42","author":"SO Keyhan","year":"2020","unstructured":"Keyhan SO, Fallahi HR, Cheshmi B (2020) Dysosmia and dysgeusia due to the 2019 novel coronavirus; a hypothesis that needs further investigation. Maxillofac Plast Reconstr Surg 42(1):9","journal-title":"Maxillofac Plast Reconstr Surg"},{"issue":"5","key":"675_CR63","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","volume":"138","author":"P Wu","year":"2020","unstructured":"Wu P et al (2020c) Characteristics of ocular findings of patients with coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 138(5):575\u2013578","journal-title":"JAMA Ophthalmol"},{"key":"675_CR64","doi-asserted-by":"crossref","unstructured":"Lukiw WJ, Pogue A, Hill JM (2020) SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol","DOI":"10.1007\/s10571-020-00947-7"},{"key":"675_CR65","doi-asserted-by":"publisher","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","volume":"194","author":"V Montalvan","year":"2020","unstructured":"Montalvan V et al (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 194:105921","journal-title":"Clin Neurol Neurosurg"},{"key":"675_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.virol.2017.12.015","volume":"517","author":"JKAGRW Millet","year":"2018","unstructured":"Millet JKAGRW (2018) Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology 517:3\u20138","journal-title":"Virology"},{"key":"675_CR67","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3389\/fimmu.2020.02163","volume":"11","author":"I Sanclemente-Alaman","year":"2020","unstructured":"Sanclemente-Alaman I et al (2020) Experimental models for the study of central nervous system infection by SARS-CoV-2. Front Immunol 11:2163","journal-title":"Front Immunol"},{"issue":"1","key":"675_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi F et al (2020) Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun 526(1):135\u2013140","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"675_CR69","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26(5):681\u2013687","journal-title":"Nat Med"},{"issue":"12","key":"675_CR70","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41594-019-0334-7","volume":"26","author":"YJ Park","year":"2019","unstructured":"Park YJ et al (2019) Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat Struct Mol Biol 26(12):1151\u20131157","journal-title":"Nat Struct Mol Biol"},{"issue":"7440","key":"675_CR71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495(7440):251\u2013254","journal-title":"Nature"},{"issue":"1","key":"675_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/1673-5374.224365","volume":"13","author":"G Al-Badri","year":"2018","unstructured":"Al-Badri G et al (2018) Tackling dipeptidyl peptidase IV in neurological disorders. Neural Regen Res 13(1):26\u201334","journal-title":"Neural Regen Res"},{"issue":"1","key":"675_CR73","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA (2020) Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microb Infect 9(1):601\u2013604","journal-title":"Emerg Microb Infect"},{"issue":"10","key":"675_CR74","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/dom.14097","volume":"22","author":"GP Fadini","year":"2020","unstructured":"Fadini GP et al (2020) Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: a case-control study. Diabetes Obes Metab 22(10):1946\u20131950","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"675_CR75","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1530\/REP-10-0069","volume":"139","author":"L Chen","year":"2010","unstructured":"Chen L et al (2010) Expression of basigin in reproductive tissues of estrogen receptor-{alpha} or -{beta} null mice. Reproduction 139(6):1057\u20131066","journal-title":"Reproduction"},{"issue":"3","key":"675_CR76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","volume":"16","author":"H Ulrich","year":"2020","unstructured":"Ulrich H, Pillat MM (2020) CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep 16(3):434\u2013440","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"675_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K et al (2020) CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5(1):1\u201310","journal-title":"Signal Transduct Target Ther"},{"key":"675_CR78","doi-asserted-by":"crossref","unstructured":"Grass GD, Toole BP (2016) How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep 36(1)","DOI":"10.1042\/BSR20150256"},{"key":"675_CR79","doi-asserted-by":"crossref","unstructured":"Bian H et al (2020) Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial. medRxiv:20040691","DOI":"10.1101\/2020.03.21.20040691"},{"issue":"1","key":"675_CR80","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41598-020-80464-1","volume":"11","author":"J Shilts","year":"2021","unstructured":"Shilts J et al (2021) No evidence for basigin\/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep 11(1):413","journal-title":"Sci Rep"},{"key":"675_CR81","doi-asserted-by":"crossref","unstructured":"Latini A et al (2020) COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. Genes (Basel) 11(9)","DOI":"10.3390\/genes11091010"},{"issue":"2","key":"675_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280.e8","journal-title":"Cell"},{"key":"675_CR83","doi-asserted-by":"crossref","unstructured":"Zang R et al (2020) TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol 5(47)","DOI":"10.1126\/sciimmunol.abc3582"},{"issue":"11","key":"675_CR84","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acschemneuro.0c00210","volume":"11","author":"K Bilinska","year":"2020","unstructured":"Bilinska K et al (2020) Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci 11(11):1555\u20131562","journal-title":"ACS Chem Neurosci"},{"key":"675_CR85","doi-asserted-by":"crossref","unstructured":"Fodoulian L et al (2020) SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. BioRxiv","DOI":"10.1101\/2020.03.31.013268"},{"issue":"9","key":"675_CR86","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1021\/acschemneuro.0c00172","volume":"11","author":"R Butowt","year":"2020","unstructured":"Butowt R, Bilinska K (2020) SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci 11(9):1200\u20131203","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"675_CR87","first-page":"4221","volume":"22","author":"J Davies","year":"2020","unstructured":"Davies J et al (2020) Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep 22(5):4221\u20134226","journal-title":"Mol Med Rep"},{"issue":"6518","key":"675_CR88","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518):856\u2013860","journal-title":"Science"},{"issue":"6518","key":"675_CR89","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370(6518):861\u2013865","journal-title":"Science"},{"key":"675_CR90","doi-asserted-by":"crossref","unstructured":"Malavolta M et al (2020) Exploring the relevance of senotherapeutics for the current SARS-CoV-2 emergency and similar future global health threats. Cell 9(4)","DOI":"10.3390\/cells9040909"},{"issue":"10","key":"675_CR91","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tcb.2020.07.002","volume":"30","author":"M Borghesan","year":"2020","unstructured":"Borghesan M et al (2020) A senescence-centric view of aging: implications for longevity and disease. Trends Cell Biol 30(10):777\u2013791","journal-title":"Trends Cell Biol"},{"issue":"10","key":"675_CR92","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/JVI.00128-13","volume":"87","author":"S Gierer","year":"2013","unstructured":"Gierer S et al (2013) The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 87(10):5502\u20135511","journal-title":"J Virol"},{"key":"675_CR93","doi-asserted-by":"crossref","unstructured":"Iwata-Yoshikawa N et al (2019) TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol 93(6)","DOI":"10.1128\/JVI.01815-18"},{"issue":"3","key":"675_CR94","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","volume":"100","author":"G Simmons","year":"2013","unstructured":"Simmons G et al (2013) Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antivir Res 100(3):605\u2013614","journal-title":"Antivir Res"},{"key":"675_CR95","doi-asserted-by":"publisher","first-page":"589505","DOI":"10.3389\/fcimb.2020.589505","volume":"10","author":"CP Gomes","year":"2020","unstructured":"Gomes CP et al (2020) Cathepsin L in COVID-19: from pharmacological evidences to genetics. Front Cell Infect Microbiol 10:589505","journal-title":"Front Cell Infect Microbiol"},{"key":"675_CR96","doi-asserted-by":"publisher","first-page":"107587","DOI":"10.1016\/j.pharmthera.2020.107587","volume":"213","author":"T Liu","year":"2020","unstructured":"Liu T et al (2020) Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients. Pharmacol Ther 213:107587","journal-title":"Pharmacol Ther"},{"key":"675_CR97","doi-asserted-by":"crossref","unstructured":"Sacco MD et al (2020) Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L. Sci Adv 6(50)","DOI":"10.1126\/sciadv.abe0751"},{"key":"675_CR98","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D et al (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 11:1446","journal-title":"Front Immunol"},{"issue":"10223","key":"675_CR99","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C et al (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"675_CR100","doi-asserted-by":"crossref","unstructured":"Costela-Ruiz VJ et al (2020) SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev","DOI":"10.1016\/j.cytogfr.2020.06.001"},{"key":"675_CR101","doi-asserted-by":"crossref","unstructured":"\u0130nand\u0131kl\u0131o\u011flu N, Akkoc T (2020) Immune responses to SARS-CoV, MERS-CoV and SARS-CoV-2. Cell Biology and translational medicine, Volume 9: Stem cell-based therapeutic approaches in disease, pp 5\u201312","DOI":"10.1007\/5584_2020_549"},{"issue":"3","key":"675_CR102","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","volume":"53","author":"D Wu","year":"2020","unstructured":"Wu D, Yang XO (2020) TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect 53(3):368\u2013370","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"675_CR103","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420\u2013422","journal-title":"Lancet Respir Med"},{"issue":"1","key":"675_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01896-0","volume":"17","author":"S Najjar","year":"2020","unstructured":"Najjar S et al (2020) Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 17(1):1\u201314","journal-title":"J Neuroinflammation"},{"key":"675_CR105","doi-asserted-by":"crossref","unstructured":"Esp\u00edndola OM et al (2021) Inflammatory cytokine patterns associated with neurological diseases in coronavirus Disease 2019. Ann Neurol","DOI":"10.1002\/ana.26041"},{"key":"675_CR106","doi-asserted-by":"publisher","first-page":"577436","DOI":"10.1016\/j.jneuroim.2020.577436","volume":"350","author":"K Keyhanian","year":"2020","unstructured":"Keyhanian K et al (2020) SARS-CoV-2 and nervous system: from pathogenesis to clinical manifestation. J Neuroimmunol 350:577436","journal-title":"J Neuroimmunol"},{"key":"675_CR107","doi-asserted-by":"crossref","unstructured":"Bodro M, Compta Y, Llans\u00f3 L, Esteller D, Doncel-Moriano A, Mesa A, Rodr\u00edguez A, Sarto J, Mart\u00ednez-Hernandez E, Vlagea A (2020a) Increased CSF levels of IL-1\u03b2, IL-6, and ACE in SARS-CoV-2\u2013associated encephalitis. Neurology\u00ae Neuroimmunol Neuroinflam 7","DOI":"10.1212\/NXI.0000000000000821"},{"key":"675_CR108","doi-asserted-by":"crossref","unstructured":"Bodro M et al (2020b) Increased CSF levels of IL-1\u03b2, IL-6, and ACE in SARS-CoV-2\u2013associated encephalitis. Neurology\u00ae Neuroimmunol Neuroinflam 7(5)","DOI":"10.1212\/NXI.0000000000000821"},{"issue":"2","key":"675_CR109","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.25783","volume":"88","author":"A Pilotto","year":"2020","unstructured":"Pilotto A et al (2020) Steroid-responsive encephalitis in coronavirus Disease 2019. Ann Neurol 88(2):423\u2013427","journal-title":"Ann Neurol"},{"key":"675_CR110","doi-asserted-by":"crossref","unstructured":"Virhammar J et al (2020) Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology","DOI":"10.1212\/WNL.0000000000010250"},{"issue":"9","key":"675_CR111","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254","journal-title":"Int J Biol Sci"},{"issue":"5","key":"675_CR112","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/ijms18051000","volume":"18","author":"DW Wojkowska","year":"2017","unstructured":"Wojkowska DW, Szpakowski P, Glabinski A (2017) Interleukin 17A promotes lymphocytes adhesion and induces CCL2 and CXCL1 release from brain endothelial cells. Int J Mol Sci 18(5):1000","journal-title":"Int J Mol Sci"},{"issue":"7","key":"675_CR113","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"LA Teuwen","year":"2020","unstructured":"Teuwen LA et al (2020) COVID-19: the vasculature unleashed. Nat Rev Immunol 20(7):389\u2013391","journal-title":"Nat Rev Immunol"},{"key":"675_CR114","doi-asserted-by":"crossref","unstructured":"Bongetta D et al (2020) Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system? Brain Behav Immun","DOI":"10.1016\/j.bbi.2020.05.050"},{"key":"675_CR115","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3389\/fimmu.2018.03022","volume":"9","author":"C Savarin","year":"2018","unstructured":"Savarin C, Bergmann CC (2018) Fine tuning the cytokine storm by IFN and IL-10 following neurotropic coronavirus encephalomyelitis. Front Immunol 9:3022","journal-title":"Front Immunol"},{"issue":"5","key":"675_CR116","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","volume":"183","author":"BJ Meckiff","year":"2020","unstructured":"Meckiff BJ et al (2020) Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19. Cell 183(5):1340\u20131353. e16","journal-title":"Cell"},{"key":"675_CR117","doi-asserted-by":"crossref","unstructured":"Bryce C et al (2020) Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. MedRxiv","DOI":"10.1101\/2020.05.18.20099960"},{"issue":"6","key":"675_CR118","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","volume":"1","author":"B Hanley","year":"2020","unstructured":"Hanley B et al (2020) Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 1(6):e245\u2013e253","journal-title":"Lancet Microbe"},{"key":"675_CR119","doi-asserted-by":"crossref","unstructured":"Ehrenfeld M et al (2020) Covid-19 and autoimmunity. Autoimmun Rev","DOI":"10.1016\/j.autrev.2020.102597"},{"issue":"17","key":"675_CR120","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.12998\/wjcc.v8.i17.3621","volume":"8","author":"R Talotta","year":"2020","unstructured":"Talotta R, Robertson E (2020) Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 8(17):3621","journal-title":"World J Clin Cases"},{"key":"675_CR121","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.jtauto.2020.100051","volume":"3","author":"J Lyons-Weiler","year":"2020","unstructured":"Lyons-Weiler J (2020) Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J Trans Autoimmun 3:100051","journal-title":"J Trans Autoimmun"},{"key":"675_CR122","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2020.07.006","volume":"81","author":"G Monti","year":"2020","unstructured":"Monti G, Giovannini G, Marudi A, Bedin R, Melegari A, Simone AM, Santangelo M, Pignatti A, Bertellini E, Trenti T (2020) Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure 81:18","journal-title":"Seizure"},{"key":"675_CR123","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbi.2020.05.054","volume":"87","author":"A Panariello","year":"2020","unstructured":"Panariello A et al (2020) Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain Behav Immun 87:179\u2013181","journal-title":"Brain Behav Immun"},{"issue":"6","key":"675_CR124","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00415-020-10201-1","volume":"268","author":"L Llorente Ayuso","year":"2021","unstructured":"Llorente Ayuso L et al (2021) Bickerstaff encephalitis after COVID-19. J Neurol 268(6):2035\u20132037","journal-title":"J Neurol"},{"key":"675_CR125","unstructured":"Ayuso LL et al (2020) Bickerstaff encephalitis after COVID-19. J Neurol:1\u20133"},{"issue":"10","key":"675_CR126","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","volume":"143","author":"RW Paterson","year":"2020","unstructured":"Paterson RW et al (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143(10):3104\u20133120","journal-title":"Brain"},{"issue":"1","key":"675_CR127","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","volume":"183","author":"C Iadecola","year":"2020","unstructured":"Iadecola C, Anrather J, Kamel H (2020b) Effects of COVID-19 on the nervous system. Cell 183(1):16\u201327. e1","journal-title":"Cell"},{"key":"675_CR128","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbi.2020.05.022","volume":"87","author":"L Dogan","year":"2020","unstructured":"Dogan L, Kaya D, Sarikaya T, Zengin R, Dincer A, Akinci IO, Afsar N (2020) Plasmapheresis treatment in COVID-19\u2013related autoimmune meningoencephalitis: case series. Brain Behav Immun 87:155\u2013158","journal-title":"Brain Behav Immun"},{"key":"675_CR129","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3389\/fneur.2020.573095","volume":"11","author":"R Chen","year":"2021","unstructured":"Chen R et al (2021) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 11:1860","journal-title":"Front Neurol"},{"key":"675_CR130","doi-asserted-by":"publisher","first-page":"662578","DOI":"10.3389\/fncel.2021.662578","volume":"15","author":"P Tavcar","year":"2021","unstructured":"Tavcar P et al (2021) Neurotropic viruses, astrocytes, and COVID-19. Front Cell Neurosci 15:662578","journal-title":"Front Cell Neurosci"},{"key":"675_CR131","doi-asserted-by":"publisher","first-page":"592214","DOI":"10.3389\/fncel.2020.592214","volume":"14","author":"ME Tremblay","year":"2020","unstructured":"Tremblay ME et al (2020) Neuropathobiology of COVID-19: the role for glia. Front Cell Neurosci 14:592214","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"675_CR132","doi-asserted-by":"publisher","first-page":"e92325","DOI":"10.1371\/journal.pone.0092325","volume":"9","author":"SS Choi","year":"2014","unstructured":"Choi SS et al (2014) Human astrocytes: secretome profiles of cytokines and chemokines. PLoS One 9(4):e92325","journal-title":"PLoS One"},{"issue":"2","key":"675_CR133","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1073858413504466","volume":"20","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew MV (2014) Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. Neuroscientist 20(2):160\u2013172","journal-title":"Neuroscientist"},{"issue":"2","key":"675_CR134","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells8020184","volume":"8","author":"S Mahmoud","year":"2019","unstructured":"Mahmoud S et al (2019) Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cell 8(2):184","journal-title":"Cell"},{"key":"675_CR135","doi-asserted-by":"crossref","unstructured":"Aghagoli G et al (2020) Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care:1\u201310","DOI":"10.1007\/s12028-020-01049-4"},{"issue":"5","key":"675_CR136","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","volume":"25","author":"SM Stamatovic","year":"2005","unstructured":"Stamatovic SM et al (2005) Monocyte chemoattractant protein-1 regulation of blood\u2013brain barrier permeability. J Cereb Blood Flow Metab 25(5):593\u2013606","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"675_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-020-02166-2","volume":"140","author":"RR Reichard","year":"2020","unstructured":"Reichard RR et al (2020) Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 140(1):1\u20136","journal-title":"Acta Neuropathol"},{"issue":"8","key":"675_CR138","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE (2019) The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol 15(8):447\u2013458","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"675_CR139","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1212\/WNL.0b013e3182a4a577","volume":"81","author":"EE Benarroch","year":"2013","unstructured":"Benarroch EE (2013) Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 81(12):1079\u20131088","journal-title":"Neurology"},{"key":"675_CR140","doi-asserted-by":"publisher","first-page":"101295","DOI":"10.1016\/j.redox.2019.101295","volume":"26","author":"C Cui","year":"2019","unstructured":"Cui C et al (2019) Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system. Redox Biol 26:101295","journal-title":"Redox Biol"},{"key":"675_CR141","doi-asserted-by":"publisher","first-page":"656700","DOI":"10.3389\/fimmu.2021.656700","volume":"12","author":"R Mishra","year":"2021","unstructured":"Mishra R, Banerjea AC (2021) SARS-CoV-2 spike targets USP33-IRF9 Axis via Exosomal miR-148a to activate human microglia. Front Immunol 12:656700","journal-title":"Front Immunol"},{"issue":"10","key":"675_CR142","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/glia.23634","volume":"67","author":"PK West","year":"2019","unstructured":"West PK et al (2019) Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease. Glia 67(10):1821\u20131841","journal-title":"Glia"},{"issue":"7","key":"675_CR143","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1128\/JVI.78.7.3398-3406.2004","volume":"78","author":"Y Li","year":"2004","unstructured":"Li Y et al (2004) Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virol 78(7):3398\u20133406","journal-title":"J Virol"},{"issue":"3","key":"675_CR144","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1172\/JCI97229","volume":"128","author":"DL Wheeler","year":"2018","unstructured":"Wheeler DL et al (2018) Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest 128(3):931\u2013943","journal-title":"J Clin Invest"},{"issue":"1","key":"675_CR145","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","volume":"27","author":"L Yang","year":"2020","unstructured":"Yang L et al (2020) A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 27(1):125\u2013136. e7","journal-title":"Cell Stem Cell"},{"issue":"2","key":"675_CR146","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.virol.2006.01.049","volume":"349","author":"H Jacomy","year":"2006","unstructured":"Jacomy H et al (2006) Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB\/C mice. Virology 349(2):335\u2013346","journal-title":"Virology"},{"issue":"1","key":"675_CR147","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s13054-020-03121-z","volume":"24","author":"G Nepal","year":"2020","unstructured":"Nepal G et al (2020) Neurological manifestations of COVID-19: a systematic review. Crit Care 24(1):421","journal-title":"Crit Care"},{"key":"675_CR148","doi-asserted-by":"crossref","unstructured":"Nersesjan V et al (2021) Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J Neurol:1\u201319","DOI":"10.1007\/s00415-020-10380-x"},{"key":"675_CR149","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbi.2020.05.012","volume":"87","author":"YH Huang","year":"2020","unstructured":"Huang YH, Jiang D, Huang JT (2020b) SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun 87:149","journal-title":"Brain Behav Immun"},{"key":"675_CR150","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.wneu.2020.05.194","volume":"140","author":"IE Efe","year":"2020","unstructured":"Efe IE et al (2020) COVID-19\u2212 associated encephalitis mimicking glial tumor. World Neurosurg 140:46\u201348","journal-title":"World Neurosurg"},{"issue":"9","key":"675_CR151","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/jnnp-2020-323816","volume":"91","author":"A Khoo","year":"2020","unstructured":"Khoo A et al (2020a) Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry 91(9):1013\u20131014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"675_CR152","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/jnnp-2020-323816","volume":"91","author":"A Khoo","year":"2020","unstructured":"Khoo A et al (2020b) Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry 91(9):1013\u20131014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"675_CR153","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7861\/clinmed.2020-0182","volume":"20","author":"PF Wong","year":"2020","unstructured":"Wong PF, Craik S, Newman P, Makan A, Srinivasan K, Crawford E, Dev D, Moudgil H, Ahmad N (2020) Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med 20(3):293","journal-title":"Clin Med"},{"key":"675_CR154","doi-asserted-by":"crossref","unstructured":"Wu X et al (2015) Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediat Inflamm 2015","DOI":"10.1155\/2015\/792578"},{"issue":"9 Supp 2","key":"675_CR155","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1212\/WNL.0000000000002825","volume":"87","author":"D Pohl","year":"2016","unstructured":"Pohl D et al (2016) Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology 87(9 Supp 2):S38\u2013S45","journal-title":"Neurology"},{"key":"675_CR156","doi-asserted-by":"publisher","first-page":"175628642098517","DOI":"10.1177\/1756286420985175","volume":"14","author":"D Ciolac","year":"2021","unstructured":"Ciolac D et al (2021) Extensive cerebellar involvement and cognitive impairment in COVID-19-associated acute necrotizing encephalopathy. Ther Adv Neurol Disord 14:1756286420985175","journal-title":"Ther Adv Neurol Disord"},{"key":"675_CR157","doi-asserted-by":"crossref","unstructured":"Dixon L et al (2020) COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflam 7(5)","DOI":"10.1212\/NXI.0000000000000789"},{"key":"675_CR158","doi-asserted-by":"crossref","unstructured":"Elkady A, Rabinstein AA (2020) Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19. Neurol Neuroimmunol Neuroinflam 7(5)","DOI":"10.1212\/NXI.0000000000000801"},{"issue":"10229","key":"675_CR159","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033","journal-title":"Lancet"},{"key":"675_CR160","doi-asserted-by":"crossref","unstructured":"Mondal R et al (2020) Spectrum of spinal cord involvement in COVID-19: a systematic review. medRxiv","DOI":"10.1101\/2020.09.29.20203554"},{"key":"675_CR161","doi-asserted-by":"crossref","unstructured":"Garg RK, Paliwal VK, Gupta A (2021) Spinal cord involvement in COVID-19: a review. J Spinal Cord Med:1\u201315","DOI":"10.1080\/10790268.2021.1888022"},{"issue":"9","key":"675_CR162","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.radcr.2020.06.001","volume":"15","author":"R AlKetbi","year":"2020","unstructured":"AlKetbi R et al (2020) Acute myelitis as a neurological complication of Covid-19: a case report and MRI findings. Radiol Case Rep 15(9):1591\u20131595","journal-title":"Radiol Case Rep"},{"key":"675_CR163","doi-asserted-by":"crossref","unstructured":"Sotoca J, Rodr\u00edguez-\u00c1lvarez Y (2020) COVID-19-associated acute necrotizing myelitis. Neurology\u00ae Neuroimmunol Neuroinflam 7(5)","DOI":"10.1212\/NXI.0000000000000803"},{"key":"675_CR164","doi-asserted-by":"crossref","unstructured":"Maideniuc C, Memon AB (2020) Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient. J Neurol:1\u20133","DOI":"10.1007\/s00415-020-10145-6"},{"key":"675_CR165","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s00415-020-09951-9","volume":"267","author":"T Parsons","year":"2020","unstructured":"Parsons T et al (2020) COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol 267:2799\u20132802","journal-title":"J Neurol"},{"key":"675_CR166","doi-asserted-by":"crossref","unstructured":"Novi G et al (2020) Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflam 7(5)","DOI":"10.1212\/NXI.0000000000000797"},{"issue":"4","key":"675_CR167","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/CS20050278","volume":"110","author":"T Wang","year":"2006","unstructured":"Wang T, Rumbaugh JA, Nath A (2006a) Viruses and the brain: from inflammation to dementia. Clin Sci (Lond) 110(4):393\u2013407","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"675_CR168","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/CS20050278","volume":"110","author":"T Wang","year":"2006","unstructured":"Wang T, Rumbaugh JA, Nath A (2006b) Viruses and the brain: from inflammation to dementia. Clin Sci 110(4):393\u2013407","journal-title":"Clin Sci"},{"issue":"Suppl 1","key":"675_CR169","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.5213\/inj.1632604.302","volume":"20","author":"H Hong","year":"2016","unstructured":"Hong H, Kim BS, Im H-I (2016) Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. Int Neurourol J 20(Suppl 1):S2","journal-title":"Int Neurourol J"},{"key":"675_CR170","doi-asserted-by":"publisher","first-page":"104474","DOI":"10.1016\/j.yexmp.2020.104474","volume":"115","author":"E Lavi","year":"2020","unstructured":"Lavi E, Cong L (2020) Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp Mol Pathol 115:104474","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"675_CR171","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S et al (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359\u20131369","journal-title":"Nat Neurosci"},{"issue":"7784","key":"675_CR172","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673","journal-title":"Nature"},{"issue":"2","key":"675_CR173","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mds.870070210","volume":"7","author":"E Fazzini","year":"1992","unstructured":"Fazzini E, Fleming J, Fahn S (1992) Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 7(2):153\u2013158","journal-title":"Mov Disord"},{"issue":"4","key":"675_CR174","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4049\/jimmunol.1501802","volume":"196","author":"BS Marro","year":"2016","unstructured":"Marro BS, Grist JJ, Lane TE (2016) Inducible expression of CXCL1 within the central nervous system amplifies viral-induced demyelination. J Immunol 196(4):1855\u20131864","journal-title":"J Immunol"},{"issue":"1","key":"675_CR175","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1128\/JVI.80.1.395-403.2006","volume":"80","author":"Y Liu","year":"2006","unstructured":"Liu Y, Pu Y, Zhang X (2006) Role of the mitochondrial signaling pathway in murine coronavirus-induced oligodendrocyte apoptosis. J Virol 80(1):395\u2013403","journal-title":"J Virol"},{"issue":"12","key":"675_CR176","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1212\/WNL.0000000000010111","volume":"95","author":"N Kanberg","year":"2020","unstructured":"Kanberg N et al (2020) Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology 95(12):e1754\u2013e1759","journal-title":"Neurology"},{"issue":"13","key":"675_CR177","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1128\/JVI.75.13.6115-6120.2001","volume":"75","author":"AA Dandekar","year":"2001","unstructured":"Dandekar AA et al (2001) Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J Virol 75(13):6115\u20136120","journal-title":"J Virol"},{"key":"675_CR178","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2020.00016","volume":"14","author":"C Mart\u00ednez-Cu\u00e9","year":"2020","unstructured":"Mart\u00ednez-Cu\u00e9 C, Rueda N (2020) Cellular senescence in neurodegenerative diseases. Front Cell Neurosci 14:16","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"675_CR179","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C et al (2013) The hallmarks of aging. Cell 153(6):1194\u20131217","journal-title":"Cell"},{"key":"675_CR180","doi-asserted-by":"crossref","unstructured":"Sfera A et al (2020) COVID-19, ferrosenescence and neurodegeneration, a mini-review. Prog Neuro-Psychopharmacol Biol Psychiatry:110230","DOI":"10.1016\/j.pnpbp.2020.110230"},{"issue":"3","key":"675_CR181","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","volume":"27","author":"OA Abiodun","year":"2020","unstructured":"Abiodun OA, Ola MS (2020) Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J Biol Sci 27(3):905\u2013912","journal-title":"Saudi J Biol Sci"},{"issue":"15","key":"675_CR182","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1101\/gad.302570.117","volume":"31","author":"KM Kim","year":"2017","unstructured":"Kim KM et al (2017) Identification of senescent cell surface targetable protein DPP4. Genes Dev 31(15):1529\u20131534","journal-title":"Genes Dev"},{"issue":"10","key":"675_CR183","doi-asserted-by":"publisher","first-page":"100814","DOI":"10.1016\/j.tranon.2020.100814","volume":"13","author":"N Singh","year":"2020","unstructured":"Singh N, Singh AB (2020) S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study. Transl Oncol 13(10):100814","journal-title":"Transl Oncol"},{"issue":"23","key":"675_CR184","doi-asserted-by":"publisher","first-page":"19687","DOI":"10.1074\/jbc.M112.350934","volume":"287","author":"X-D Liu","year":"2012","unstructured":"Liu X-D et al (2012) Transient aggregation of ubiquitinated proteins is a cytosolic unfolded protein response to inflammation and endoplasmic reticulum stress. J Biol Chem 287(23):19687\u201319698","journal-title":"J Biol Chem"},{"issue":"22","key":"675_CR185","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acschemneuro.0c00676","volume":"11","author":"O Tavassoly","year":"2020","unstructured":"Tavassoly O, Safavi F, Tavassoly I (2020) Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection. ACS Chem Neurosci 11(22):3704\u20133706","journal-title":"ACS Chem Neurosci"},{"issue":"20","key":"675_CR186","doi-asserted-by":"publisher","first-page":"e106230","DOI":"10.15252\/embj.2020106230","volume":"39","author":"A Ramani","year":"2020","unstructured":"Ramani A et al (2020) SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J 39(20):e106230","journal-title":"EMBO J"},{"issue":"6","key":"675_CR187","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/JVI.02949-15","volume":"90","author":"EL Beatman","year":"2016","unstructured":"Beatman EL et al (2016) Alpha-synuclein expression restricts RNA viral infections in the brain. J Virol 90(6):2767\u20132782","journal-title":"J Virol"},{"key":"675_CR188","doi-asserted-by":"crossref","unstructured":"Blanco-Palmero V et al (2021) Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms. J Neurol:1\u20139","DOI":"10.1007\/s00415-021-10444-6"},{"issue":"12","key":"675_CR189","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1906466117","volume":"117","author":"R Marreiros","year":"2020","unstructured":"Marreiros R et al (2020) Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation. Proc Natl Acad Sci U S A 117(12):6741\u20136751","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"675_CR190","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/mdc3.12965","volume":"7","author":"A Fasano","year":"2020","unstructured":"Fasano A et al (2020) Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID-19 experience. Mov Disord Clin Pract 7(4):361\u2013372","journal-title":"Mov Disord Clin Pract"},{"issue":"8","key":"675_CR191","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/mds.28170","volume":"35","author":"R Cilia","year":"2020","unstructured":"Cilia R et al (2020) Effects of COVID-19 on Parkinson's disease clinical features: a community-based case-control study. Mov Disord 35(8):1287\u20131292","journal-title":"Mov Disord"},{"issue":"7","key":"675_CR192","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/mds.28134","volume":"35","author":"A Shalash","year":"2020","unstructured":"Shalash A et al (2020) Mental health, physical activity, and quality of life in Parkinson\u2019s Disease during COVID-19 pandemic. Mov Disord 35(7):1097\u20131099","journal-title":"Mov Disord"},{"key":"675_CR193","doi-asserted-by":"crossref","unstructured":"Salari M et al (2020) Incidence of anxiety in Parkinson's disease during the coronavirus disease (COVID-19) pandemic. Mov Disord","DOI":"10.1016\/j.yebeh.2020.107442"},{"key":"675_CR194","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/bs.pmbts.2019.06.002","volume":"168","author":"CT Tulisiak","year":"2019","unstructured":"Tulisiak CT et al (2019) Can infections trigger alpha-synucleinopathies? Prog Mol Biol Transl Sci 168:299\u2013322","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"10","key":"675_CR195","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1474-4422(20)30305-7","volume":"19","author":"ME Cohen","year":"2020","unstructured":"Cohen ME et al (2020) A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol 19(10):804\u2013805","journal-title":"Lancet Neurol"},{"key":"675_CR196","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12603-020-1389-1","volume":"24","author":"A Bianchetti","year":"2020","unstructured":"Bianchetti A et al (2020) Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging 24:560\u2013562","journal-title":"J Nutr Health Aging"},{"key":"675_CR197","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","volume":"9","author":"IM Rea","year":"2018","unstructured":"Rea IM et al (2018) Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol 9:586","journal-title":"Front Immunol"},{"issue":"9","key":"675_CR198","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/ene.14339","volume":"27","author":"B Lara","year":"2020","unstructured":"Lara B et al (2020) Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer\u2019s disease during the COVID-19 lockdown. Eur J Neurol 27(9):1744\u20131747","journal-title":"Eur J Neurol"},{"issue":"1","key":"675_CR199","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13365-021-00954-4","volume":"27","author":"J Hellmuth","year":"2021","unstructured":"Hellmuth J et al (2021) Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol 27(1):191\u2013195","journal-title":"J Neurovirol"},{"key":"675_CR200","doi-asserted-by":"crossref","unstructured":"Naughton SX, Raval U, Pasinetti GM (2020) Potential novel role of COVID-19 in Alzheimer\u2019s disease and preventative mitigation strategies. J Alzheimer\u2019s Dis (Preprint):1\u20135","DOI":"10.3233\/JAD-200537"},{"key":"675_CR201","doi-asserted-by":"crossref","unstructured":"Ferini-Strambi L, Salsone M (2020) COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol:1\u201311","DOI":"10.1007\/s00415-020-10070-8"},{"key":"675_CR202","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.bbi.2020.07.007","volume":"89","author":"MJ Young","year":"2020","unstructured":"Young MJ et al (2020) Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav Immun 89:601\u2013603","journal-title":"Brain Behav Immun"},{"issue":"12","key":"675_CR203","doi-asserted-by":"publisher","first-page":"omaa113","DOI":"10.1093\/omcr\/omaa113","volume":"2020","author":"CE McMurran","year":"2020","unstructured":"McMurran CE, Chaggar GH, Ugoya SO (2020) A patient with sporadic Creutzfeldt\u2013Jakob disease: challenges of rare diseases in the COVID-19 era. Oxford Med Case Rep 2020(12):omaa113","journal-title":"Oxford Med Case Rep"},{"issue":"19","key":"675_CR204","doi-asserted-by":"publisher","first-page":"7299","DOI":"10.3390\/ijms21197299","volume":"21","author":"NA Mabbott","year":"2020","unstructured":"Mabbott NA et al (2020) The effects of immune system modulation on prion disease susceptibility and pathogenesis. Int J Mol Sci 21(19):7299","journal-title":"Int J Mol Sci"},{"issue":"1","key":"675_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03267-w","volume":"24","author":"G Riva","year":"2020","unstructured":"Riva G et al (2020) COVID-19: more than a cytokine storm. Crit Care 24(1):1\u20133","journal-title":"Crit Care"},{"key":"675_CR206","unstructured":"Vabret N et al (2020) Immunology of COVID-19: current state of the science. Immunity"},{"key":"675_CR207","doi-asserted-by":"publisher","first-page":"173372","DOI":"10.1016\/j.ejphar.2020.173372","volume":"883","author":"P Chibber","year":"2020","unstructured":"Chibber P et al (2020) Advances in the possible treatment of COVID-19: a review. Eur J Pharmacol 883:173372","journal-title":"Eur J Pharmacol"},{"key":"675_CR208","doi-asserted-by":"crossref","unstructured":"Lamb YN (2020) Remdesivir: first approval. Drugs:1\u20139","DOI":"10.1007\/s40265-020-01378-w"},{"key":"675_CR209","volume-title":"Remdesivir and its antiviral activity against COVID-19: a systematic review","author":"A Frediansyah","year":"2020","unstructured":"Frediansyah A et al (2020) Remdesivir and its antiviral activity against COVID-19: a systematic review. Clinical epidemiology and global health"},{"issue":"11","key":"675_CR210","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1001\/jama.2020.16337","volume":"324","author":"EK McCreary","year":"2020","unstructured":"McCreary EK, Angus DC (2020) Efficacy of Remdesivir in COVID-19. JAMA 324(11):1041\u20131042","journal-title":"JAMA"},{"issue":"6","key":"675_CR211","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.arcmed.2020.05.009","volume":"51","author":"A Saha","year":"2020","unstructured":"Saha A et al (2020) Tocilizumab: a therapeutic option for the treatment of cytokine storm syndrome in COVID-19. Arch Med Res 51(6):595\u2013597","journal-title":"Arch Med Res"},{"key":"675_CR212","doi-asserted-by":"publisher","first-page":"577400","DOI":"10.1016\/j.jneuroim.2020.577400","volume":"349","author":"L Muccioli","year":"2020","unstructured":"Muccioli L et al (2020) COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment. J Neuroimmunol 349:577400","journal-title":"J Neuroimmunol"},{"key":"675_CR213","doi-asserted-by":"crossref","unstructured":"Romero A et al (2020) Coronavirus Disease 2019 (COVID-19) and its neuroinvasive capacity: is it time for melatonin? Cell Mol Neurobiol:1\u201312","DOI":"10.22541\/au.158879406.61360122"},{"issue":"3","key":"675_CR214","doi-asserted-by":"publisher","first-page":"264","DOI":"10.32794\/mr11250061","volume":"3","author":"R Hardeland","year":"2020","unstructured":"Hardeland R, Tan D-X (2020) Protection by melatonin in respiratory diseases: valuable information for the treatment of COVID-19. Melatonin Res 3(3):264\u2013275","journal-title":"Melatonin Res"},{"issue":"29","key":"675_CR215","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2217\/nnm-2020-0371","volume":"15","author":"VM Martin Gimenez","year":"2020","unstructured":"Martin Gimenez VM et al (2020) New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment. Nanomedicine (Lond) 15(29):2819\u20132821","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"675_CR216","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1002\/rmv.2109","volume":"30","author":"G Anderson","year":"2020","unstructured":"Anderson G, Reiter RJ (2020) Melatonin: roles in influenza, Covid-19, and other viral infections. Rev Med Virol 30(3):e2109","journal-title":"Rev Med Virol"},{"issue":"2","key":"675_CR217","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/toxins5020363","volume":"5","author":"AA Maghazachi","year":"2013","unstructured":"Maghazachi AA (2013) On the role of natural killer cells in neurodegenerative diseases. Toxins 5(2):363\u2013375","journal-title":"Toxins"},{"issue":"1","key":"675_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15644-8","volume":"11","author":"S Garofalo","year":"2020","unstructured":"Garofalo S et al (2020) Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis. Nat Commun 11(1):1\u201316","journal-title":"Nat Commun"},{"key":"675_CR219","doi-asserted-by":"publisher","first-page":"154260","DOI":"10.1016\/j.metabol.2020.154260","volume":"108","author":"M Dalamaga","year":"2020","unstructured":"Dalamaga M, Karampela I, Mantzoros CS (2020) Commentary: could iron chelators prove to be useful as an adjunct to COVID-19 treatment regimens? Metabolism 108:154260","journal-title":"Metabolism"},{"issue":"35","key":"675_CR220","doi-asserted-by":"publisher","first-page":"E5192","DOI":"10.1073\/pnas.1603435113","volume":"113","author":"Y Ma-Lauer","year":"2016","unstructured":"Ma-Lauer Y et al (2016) p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci 113(35):E5192\u2013E5201","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"675_CR221","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.4161\/cc.10.21.17899","volume":"10","author":"C Mu\u00f1oz-Fontela","year":"2011","unstructured":"Mu\u00f1oz-Fontela C et al (2011) Acetylation is indispensable for p53 antiviral activity. Cell Cycle 10(21):3701\u20133705","journal-title":"Cell Cycle"},{"issue":"3","key":"675_CR222","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3(3):153\u2013165","journal-title":"Cell Metab"},{"issue":"2","key":"675_CR223","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.diabet.2020.11.005","volume":"47","author":"AJ Scheen","year":"2021","unstructured":"Scheen AJ (2021) DPP-4 inhibition and COVID-19: from initial concerns to recent expectations. Diabetes Metab 47(2):101213","journal-title":"Diabetes Metab"},{"key":"675_CR224","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","volume":"104","author":"SJ Guiney","year":"2017","unstructured":"Guiney SJ et al (2017) Ferroptosis and cell death mechanisms in Parkinson's disease. Neurochem Int 104:34\u201348","journal-title":"Neurochem Int"},{"key":"675_CR225","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3389\/fnins.2019.01443","volume":"13","author":"N Yan","year":"2020","unstructured":"Yan N, Zhang J (2020) Iron metabolism, ferroptosis, and the links with Alzheimer\u2019s disease. Front Neurosci 13:1443","journal-title":"Front Neurosci"}],"container-title":["Advances in Experimental Medicine and Biology","Cell Biology and Translational Medicine, Volume 15"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2021_675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T21:08:56Z","timestamp":1700082536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2021_675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783031023774","9783031023781"],"references-count":225,"URL":"https:\/\/doi.org\/10.1007\/5584_2021_675","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"5 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}